Jeffrey M. Liebman - Concepedia

Author

Jeffrey M. Liebman

Also Known As

J LIEBMAN, J M Liebman, J. Liebman, J. M. LIEBMAN, J.M. Liebman, JEFFREY LIEBMAN, JEFFREY M. LIEBMAN, Jeffrey Liebman, Jeffrey M. Liebman

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Novartis (Switzerland)University of California, Los Angeles University of California San Diego Novartis (United States)

About

Jeffrey M. Liebman is an author at Novartis (Switzerland) specializing in medicine, neuropharmacology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	44	1.7K
2	Social Sciences	18	24	1.4K
3	Health Sciences	6	6	232
4	Natural Sciences	1	1	15
5	Anesthesia	1	1	58

Jeffrey M. Liebman

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
The N-methyl-d-aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbils Carl A. Boast, Susan Gerhardt, Gary Pastor, Brain Research NeuropeptidesNeurophysiologyMedicineNeuropharmacologyBrain Injury	1988	247
Mesencephalic central gray lesions and fear-motivated behavior in rats Jeffrey M. Liebman, David Mayer, John C. Liebeskind Brain Research Neurobiological MechanismNeuropsychologyFear-motivated BehaviorBehavioral NeuroscienceNeuroanatomy	1970	240
Unique behavioral effects of the NMDA antagonist, CPP, upon injection into the medial pre-frontal cortex of rats Katherine A. O'Neill, Jeffrey M. Liebman Brain Research Unique Behavioral EffectsNeurophysiologyNeuroanatomyBehavioral NeuroscienceBehavioral Pharmacology	1987	155
Effects on self-stimulation behavior of drugs influencing dopaminergic neurotransmission mechanisms Jeffrey M. Liebman, Larry L. Butcher Naunyn-Schmiedeberg s Archives of Pharmacology Psychoactive DrugBehavioral NeuroscienceAddictionNeurophysiologySelf-stimulation Behavior	1973	119
Comparative involvement of dopamine and noradrenaline in rate-free self-stimulation in substantia nigra, lateral hypothalamus, and mesencephalic central gray Jeffrey M. Liebman, Larry L. Butcher Naunyn-Schmiedeberg s Archives of Pharmacology Neurobiological MechanismPsychiatryHypothalamusNeuroanatomyNeurophysiology	1974	91
Antagonism by mianserin and classical α-adrenoceptor blocking drugs of some cardiovascular and behavioral effects of clonidine Ronald D. Robson, Michael J. Antonaccio, Jeffrey K. Saelens, European Journal of Pharmacology Molecular PharmacologyMedicineBehavioural PharmacologyBehavioral PharmacologyPhysiology	1978	82
CGS 9896: agonist-antagonist benzodiazepine receptor activity revealed by anxiolytic, anticonvulsant and muscle relaxation assessment in rodents. Patrick S. Bernard, D A Bennett, Gary Pastor, Journal of Pharmacology and Experimental Therapeutics	1985	73
Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptors. D A Bennett, Patrick S. Bernard, Caryl L. Amrick, Journal of Pharmacology and Experimental Therapeutics	1989	73
Dopamine neurochemical profile of atypical antipsychotics resembles that of D-1 antagonists C. Anthony Altar, William C. Boyar, Annemarie Wasley, Naunyn-Schmiedeberg s Archives of Pharmacology NeuropsychologyPsychoactive DrugPsychiatryAtypical AntipsychoticsMedicine	1988	69
Self-stimulation loci in the midbrain central gray matter of the rat Jeffrey M. Liebman, David J. Mayer, John C. Liebeskind Behavioral Biology Neurobiological MechanismNeurophysiologyNeuroanatomyMedicinePhysiology	1973	67

Page 1